How large is the nucleic acid amplification testing market, and what is its growth trajectory?
The nucleic acid amplification testing market size has grown rapidly in recent years. It will grow from $9.56 $ billion in 2024 to $11.03 $ billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to rising awareness of infectious disease diagnosis, the emergence of new pathogens, the shift towards personalized medicine, demand for point-of-care testing, regulatory approvals, and guidelines.
The nucleic acid amplification testing market size is expected to see rapid growth in the next few years. It will grow to $19.26 $ billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the increasing incidence of infectious diseases, the need for large-scale testing capabilities, increasing investments from private companies, increasing demand for rapid and accurate testing methods, and increasing demand for advanced diagnostic measures. Major trends in the forecast period include integration with artificial intelligence (AI), advancement in wearable and implantable devices, growing adoption in point-of-care testing, expansion in personalized medicine, and integration with digital health technologies.
Get Your Free Sample of The Global Nucleic Acid Amplification Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19619&type=smp
What are the key forces behind the nucleic acid amplification testing market’s growth in recent years?
The increasing incidence of infectious diseases is expected to propel the growth of the nucleic acid amplification testing market going forward. Infectious diseases are conditions caused by organisms that can spread directly or indirectly from one person to another via various means, such as physical contact, airborne transmission, contaminated food or water, or vector-borne spread via insects. The increase in infectious diseases is due to antibiotic resistance, climate change, changes in human behavior, and agricultural practices. Nucleic acid amplification testing (NAAT) rapidly and accurately identifies infectious pathogens, facilitating timely diagnosis and treatment, thereby helping to control the spread of diseases. For instance, in October 2023, according to the Public Health Agency of Canada, a Canada-based government agency, in the 2022–2023 season, participating provinces and territories reported 4,216 hospitalizations related to influenza. Therefore, the increasing incidence of infectious diseases drives the growth of the nucleic acid amplification testing market.
What are the major segments of the nucleic acid amplification testing market?
The nucleic acid amplification testingmarket covered in this report is segmented –
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Product Type: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification
Order your report now for swift delivery
Which companies dominate the nucleic acid amplification testing market?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation
What major trends will shape the nucleic acid amplification testing market during the forecast period?
Major companies operating in the nucleic acid amplification testing market are focusing on developing innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for CMV by nucleic acid amplification technology (NAT) under the IVDR. An IVD (in vitro diagnostic) assay is a test performed on biological samples to detect diseases, conditions, or infections outside the body in a laboratory setting. For instance, in June 2024, GFE, a Germany-based company, launched the PoET CMV. PoET CMV, an IVD assay, is designed for the rapid and precise detection of cytomegalovirus (CMV) infections. Its unique features include high sensitivity and specificity, allowing for early diagnosis and effective monitoring of CMV in transplant patients and immunocompromised individuals. The assay utilizes advanced molecular techniques to deliver reliable results quickly, supporting timely clinical decision-making.
What are the key regional dynamics of the nucleic acid amplification testing market, and which region leads in market share?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Nucleic Acid Amplification Testing Market Report 2025 Offer?
The nucleic acid amplification testing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Nucleic acid amplification testing (NAAT) refers to molecular techniques that detect and amplify specific deoxyribose nucleic acid (DNA) or ribose nucleic acid (RNA) in a sample. It is widely used for identifying pathogens at early infection stages due to its high sensitivity. Researchers use NAAT to study gene expression, genetic variations, and disease mechanisms, aiding in understanding genetic disease bases and developing targeted therapies.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19619
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
